Insight Molecular Diagnostics, Inc. (IMDX)
6.25
-0.16
(-2.50%)
USD |
NASDAQ |
May 18, 15:20
Insight Molecular Diagnostics EPS Diluted (Quarterly) : -0.1243 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Veracyte, Inc. | 0.353 |
| Exagen, Inc. | -0.1663 |
| bioAffinity Technologies, Inc. | -0.8077 |
| GRAIL, Inc. | -2.293 |
| FONAR Corp. | 0.2441 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.29M |
| Revenue (Quarterly) | 0.032M |
| Total Expenses (Quarterly) | 4.322M |
| Enterprise Value | 181.12M |
| Gross Profit Margin (Quarterly) | -1.89K% |
| Profit Margin (Quarterly) | -13.41K% |
| Earnings Yield | -23.73% |
| Normalized Earnings Yield | -18.78 |